Dr Reddys Laboratories shares rise 2.17% in early trade

Dr Reddys Laboratories shares gained 2.17% in Tuesday's early trading session, reaching a price of Rs 1,277.80 at 09:24 am. The stock is a constituent of the Nifty 50 index.

Consolidated Quarterly Financials:

The following table summarizes the consolidated quarterly income statement of Dr Reddys Laboratories:

The revenue for the quarter ending June 2025 stood at Rs 8,572.10 Crore, a slight increase compared to Rs 8,528.40 Crore for the quarter ending March 2025. The net profit for the quarter ending June 2025 was Rs 1,409.70 Crore, while the quarter ending March 2025 saw a net profit of Rs 1,581.20 Crore.

Consolidated Yearly Financials:

The following table summarizes the consolidated yearly income statement of Dr Reddys Laboratories:

The revenue for the year ending March 2025 was Rs 32,643.90 Crore, an increase from the Rs 28,011.10 Crore reported for the year ending March 2024. Net profit also increased from Rs 5,563.20 Crore in March 2024 to Rs 5,703.50 Crore in March 2025.

Consolidated Balance Sheet:

The following table presents the consolidated balance sheet of Dr Reddys Laboratories:

Consolidated Cash Flow:

The following table shows the consolidated cash flow statement:

Key Financial Ratios:

The Basic Earnings per Share (EPS) stood at Rs 67.89 as of March 2025, compared to Rs 335.22 in March 2024. The Return on Networth/Equity was 16.85% in March 2025, while it was 19.74% in March 2024. The debt to equity ratio stood at 0.12 as of March 2025.

Corporate Actions:

• Bonus Issues: The company has a history of bonus issues, including a 1:1 bonus on May 31, 2006, with an ex-bonus date of August 28, 2006.
• Stock Splits: Dr Reddys Laboratories has split its stock, with the latest split occurring on July 27, 2024, which changed the face value from Rs 5 to Rs 1, effective from October 28, 2024.
• Dividends: The company announced a final dividend of Rs 8 per share on May 9, 2025, with the ex-date being July 10, 2025.

Moneycontrol analysis indicates a bullish sentiment on the stock as of September 2, 2025.

With the stock currently trading at Rs 1,277.80, Dr Reddys Laboratories has demonstrated a positive start in today's session, driven by a rise of 2.17%.